Tokyo, Japan

Satashi Sato

This inventor holds 1 USPTO granted patent. Top assignee: Freund Industry Company, Limited. Active years: 1985.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Satashi Sato. Retrieved from https://idiyas.com/inventor/satashi-sato

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 141(Granted Patents)


Company Filing History:


Years Active: 1985

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Satashi Sato

Introduction

Satashi Sato is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of activated pharmaceutical compositions. His innovative approach has the potential to enhance drug absorption and efficacy.

Latest Patents

Satashi Sato holds a patent for a process that prepares activated pharmaceutical compositions. This process involves using a solid drug that is scarcely soluble in water. The unique method allows for the drug to be dispersed in water with the help of a water-soluble high-molecular substance. This results in finely divided particles that are easily absorbed when administered orally, leading to a rapid increase in blood concentration.

Career Highlights

Sato is associated with Freund Industry Company, Limited, where he applies his expertise in pharmaceutical innovations. His work focuses on improving drug formulations to enhance patient outcomes. With a patent count of 1 patent, he continues to contribute to advancements in the pharmaceutical industry.

Collaborations

Some of his notable coworkers include Shimesu Motoyama and Seiichi Umeda. Their collaborative efforts in research and development have furthered the goals of their organization.

Conclusion

Satashi Sato's innovative work in the pharmaceutical field exemplifies the impact of effective drug formulation processes. His contributions are paving the way for improved therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…